[HTML][HTML] Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia

A Yap, MA Lopez-Olivo, J Dubowitz, J Hiller… - Canadian Journal of …, 2019 - infona.pl
Comparative studies examining the effect of inhalational volatile anesthesia and propofol-based
total intravenous anesthesia (TIVA) on cancer outcomes were included. The Newcastle …

… inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis

U Dafni, Z Tsourti, K Vervita, S Peters - Lung cancer, 2019 - Elsevier
… The various options suffer the lack of direct cross-comparison studies, and inter-trial
comparisons are of particular risk for inaccuracy, in the context of differences in study patients’ …

Green synthesis of zinc oxide nanoparticles using Citrus sinensis peel extract and application to strawberry preservation: A comparison study

Y Gao, D Xu, D Ren, K Zeng, X Wu - Lwt, 2020 - Elsevier
… This study demonstrated the successful synthesis of SNP using the extract of Citrus sinensis
peel, and the comparison in structure, properties and coating preservation effects with CNP. …

Cancer statistics in China and United States, 2022: profiles, trends, and determinants

C Xia, X Dong, H Li, M Cao, D Sun, S He… - Chinese medical …, 2022 - mednexus.org
… and policy making around cancer prevention in China. We therefore carried out a comparative
study to report cancer burden, long-term trends in cancer incidence and mortality rates, …

Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation–Positive Non–Small Cell Lung Cancer

K Isomoto, K Haratani, H Hayashi, S Shimizu… - … Cancer Research, 2020 - AACR
… Previous studies have found limited clinical benefit of treatment with immune-checkpoint
inhibitors (ICI) in patients with non–small cell lung cancer harboring activating mutations of the …

[HTML][HTML] … overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study

T Mok, DR Camidge, SM Gadgeel, R Rosell… - Annals of oncology, 2020 - Elsevier
… Five-year relative survival rates for patients with metastatic non-small-cell lung cancer (NSCLC)
remain extremely low, and were estimated to be just 6.1% for those diagnosed between …

Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer

KN Shah, R Bhatt, J Rotow, J Rohrberg, V Olivas… - Nature medicine, 2019 - nature.com
… The approval and use of epidermal growth factor receptor (EGFR) inhibitors in EGFR-mutant
non-small-cell lung cancer (NSCLC) has been a major clinical breakthrough, helping to …

Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline …

M Reck, TSK Mok, M Nishio, RM Jotte… - The Lancet …, 2019 - thelancet.com
… versus docetaxel in patients with previously treated non-small-cell lung cancer regardless
of PD-L1 expression. Several ongoing studies in patients with non-small-cell lung cancer are …

Evaluation of first-line radiosurgery vs whole-brain radiotherapy for small cell lung cancer brain metastases: the FIRE-SCLC cohort study

CG Rusthoven, M Yamamoto, D Bernhardt… - … oncology, 2020 - jamanetwork.com
… point between small cell lung cancer and non–small cell lung cancer, and the outcomes
in the small cell lung cancer cohort were comparable to results of the present analysis (median …

Radiomics of brain MRI: utility in prediction of metastatic tumor type

HC Kniep, F Madesta, T Schneider, U Hanning… - Radiology, 2019 - pubs.rsna.org
Comparative analysis of 10 randomly drawn cross-validation sets verified the stability of the
results… Stability of results was verified through comparative analysis of 10 randomly permuted …